3-methyl-1-(3-phenylpropyl)piperidine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-methyl-1-(3-phenylpropyl)piperidine
• 英文别名: 3-Methyl-1-(3-phenyl-propyl)-piperidine
• 化学式: C₁₅H₂₃N
• 分子量: 217.354
• InChiKey: JPOWDQIFWMJSIN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  3-甲基哌啶 、 alkaline earth salt of/the/ methylsulfuric acid 在 碳酸氢钠 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 3-methyl-1-(3-phenylpropyl)piperidine
  参考文献：
  名称：

  N-Arylalkylpiperidines as High-Affinity Sigma-1 and Sigma-2 Receptor Ligands: Phenylpropylamines as Potential Leads for Selective Sigma-2 Agents

  摘要：

  To delineate the differences between the structural requirements necessary for recognition at sigma-1 and sigma-2 receptors, a range of phenethyl- and phenylpropylpiperidines were evaluated in binding assays. Phenethylpiperidines were found to favor sigma-1 receptors, whereas phenylpropylpiperidines tend to favor sigma-2 receptors. It appears that phenylpropylamine is a potential pharmacophore for selective sigma-2 ligands. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00788-0

文献信息

• A General Acid‐Mediated Hydroaminomethylation of Unactivated Alkenes and Alkynes
  作者：Daniel Kaiser、Veronica Tona、Carlos R. Gonçalves、Saad Shaaban、Alberto Oppedisano、Nuno Maulide

  DOI：10.1002/anie.201906910

  日期：2019.10.7

  its considerable potential to streamline amine synthesis. State-of-the-art protocols for hydroaminomethylation of alkenes rely largely on transition-metal catalysis, enabling this transformation only under highly designed and controlled conditions. Here we report a broadly applicable, acid-mediated approach to the hydroaminomethylation of unactivated alkenes and alkynes. This methodology employs cheap

  与广泛研究的金属催化加氢胺化反应相比，加氢氨甲基化尽管具有极大的简化胺合成的潜力，但受到的关注却很少。烯烃加氢氨基甲基化的最新方案主要依赖于过渡金属催化，只有在高度设计和控制的条件下才能进行这种转化。在这里，我们报告了一种广泛适用的酸介导的方法，用于未活化的烯烃和炔烃的氢氨基甲基化。该方法采用廉价，易于获得且稳定的反应物，并提供所需的胺，且具有出色的官能团耐受性和无可挑剔的区域选择性。报道了这种转变的广泛范围，以及机理研究和原位多米诺骨牌功能化反应。
• [EN] HETEROCYCLIC ANALGESIC COMPOUNDS AND METHOD OF USE THEREOF<br/>[FR] COMPOSES ANALGESIQUES HETEROCYCLIQUES ET TECHNIQUE D'UTILISATION DE CEUX-CI
  申请人：SEPRACOR INC

  公开号：WO2001092226A1

  公开（公告）日：2001-12-06

  One aspect of the present invention relates to novel heterocyclic compounds, such as Formula (1). A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the invention relates to the use of the novel heterocyclic compounds as analgesics.